Escalating the dose of YFV-17D (107 PFU) increased the mortality rate of αβR−/− λR−/− mice (survival rate at 9 days postinfection, 40%), but more than 90% of the αβR−/− and λR−/− survived the viral infection (Fig. 1B). Here, ABR is linked to viral infectious disease.